Applying support-vector machine learning algorithms toward predicting host-guest interactions with cucurbit[7]uril.

Machine learning is a valuable tool in the development of chemical technologies but its applications into supramolecular chemistry have been limited. Here, the utility of kernel-based support vector machine learning using density functional theory calculations as training data is evaluated when used to predict equilibrium binding coefficients of small molecules with cucurbit[7]uril (CB[7]). We find that utilising SVMs may confer some predictive ability. This algorithm was then used to predict the binding of drugs TAK-580 and selumetinib. The algorithm did predict strong binding for TAK-580 and poor binding for selumetinib, and these results were experimentally validated. It was discovered that the larger homologue cucurbit[8]uril (CB[8]) is partial to selumetinib, suggesting an opportunity for tunable release by introducing different concentrations of CB[7] or CB[8] into a hydrogel depot. We qualitatively demonstrated that these drugs may have utility in combination against gliomas. Finally, mass transfer simulations show CB[7] can independently tune the release of TAK-580 without affecting selumetinib. This work gives specific evidence that a machine learning approach to recognition of small molecules by macrocycles has merit and reinforces the view that machine learning may prove valuable in the development of drug delivery systems and supramolecular chemistry more broadly.

[1]  O. Scherman,et al.  Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril. , 2012, Chemical communications.

[2]  A. Bernkop‐Schnürch,et al.  Strategies to improve plasma half life time of peptide and protein drugs , 2006, Amino Acids.

[3]  M. Frisch,et al.  Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields , 1994 .

[4]  Pieter P. Plehiers,et al.  A robotic platform for flow synthesis of organic compounds informed by AI planning , 2019, Science.

[5]  D. Matak-Vinkovic,et al.  Mining 2:2 Complexes from 1:1 Stoichiometry: Formation of Cucurbit[8]uril-Diarylviologen Quaternary Complexes Favored by Electron-Donating Substituents. , 2017, Journal of the American Chemical Society.

[6]  E. Rosta,et al.  Cucurbit[7]uril as a Supramolecular Artificial Enzyme for Diels-Alder Reactions. , 2017, Angewandte Chemie.

[7]  V. Sondak,et al.  Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma , 2013, Nature Reviews Clinical Oncology.

[8]  Michael J. Keiser,et al.  Comment on “Predicting reaction performance in C–N cross-coupling using machine learning” , 2018, Science.

[9]  Q. Lan,et al.  CSIG-19. FHL2 INTERACTS WITH EGFRVIII TO PROMOTE GLIOBLASTOMA GROWTH , 2017 .

[10]  David L. Mobley,et al.  The SAMPL4 host–guest blind prediction challenge: an overview , 2014, Journal of Computer-Aided Molecular Design.

[11]  P. Patil,et al.  Designing Next‐Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic , 2019, Advanced healthcare materials.

[12]  Regina Barzilay,et al.  Prediction of Organic Reaction Outcomes Using Machine Learning , 2017, ACS central science.

[13]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[14]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[15]  O. Scherman,et al.  Mechanical Characterization of Human Brain Tissue and Soft Dynamic Gels Exhibiting Electromechanical Neuro‐Mimicry , 2019, Advanced healthcare materials.

[16]  Masoumeh Haghpanahi,et al.  Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network , 2019, Nature Medicine.

[17]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[18]  Chun Wang,et al.  Gels without Vapor Pressure: Soft, Nonaqueous, and Solvent‐Free Supramolecular Biomaterials for Prospective Parenteral Drug Delivery Applications , 2018, Advanced healthcare materials.

[19]  Oren A Scherman,et al.  Cucurbituril-Based Molecular Recognition. , 2015, Chemical reviews.

[20]  C. Abell,et al.  Biomimetic Supramolecular Polymer Networks Exhibiting both Toughness and Self‐Recovery , 2017, Advanced materials.

[21]  Nan Li,et al.  Tough Supramolecular Polymer Networks with Extreme Stretchability and Fast Room‐Temperature Self‐Healing , 2017, Advanced materials.

[22]  W. Hahn,et al.  A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas , 2017, Neuro-oncology.

[23]  Shengke Li,et al.  Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients , 2017, Annals of the New York Academy of Sciences.

[24]  R. Fisher,et al.  Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma , 2019, Nature Medicine.

[25]  Connor W. Coley,et al.  Machine Learning in Computer-Aided Synthesis Planning. , 2018, Accounts of chemical research.

[26]  M. Prados,et al.  A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study , 2017, Neuro-oncology.